表紙SALE
市場調查報告書
商品編碼
998647

學名藥的全球市場:各類型、各用途、藥物輸送的各途徑、各形狀、採購處、各流通管道、各企業、各地區的未來預測與市場機會 (2026年)

Global Generic Drugs Market, By Type, By Application, By Drug Delivery, By Form, By Source, By Distribution Channel, By Company, By Region, Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球學名藥的市場規模,2020年達到3710億4000萬美元,預計至2026年達5644億3000萬美元。

在預測期間內預計以7.08%的年複合成長率成長。市場主要促進因素,是慢性疾病的盛行率上升等。在各地區中,在亞太地區各國的市場今後預計大幅度成長。

本報告提供全球學名藥的市場相關分析,整體市場規模趨勢預測和市場佔有率結構 (各類型、各用途、藥物輸送的各途徑、各形狀、各採購處、各流通管道) 、各地區、主要國家詳細趨勢 (2016年∼2020年/2021年∼2026年),主要的推動及阻礙市場要素,企業間的市場競爭結構,主要企業的簡介,今後的市場成長的方向性等調查。

目錄

第1章 產品概要

第2章 分析方法

第3章 COVID-19對全球學名藥市場的影響

第4章 摘要整理

第5章 客戶方面的見解

  • 品牌認知度
  • 全球學名藥市場促進因素
  • 醫藥品購買決策的影響因素

第6章 全球學名藥市場:未來展望

  • 市場規模與其預測
    • 以金額為準
  • 市場佔有率與其預測
    • 各類型 (小分子非專利,生物相似藥)
    • 各用途 (心血管疾病,糖尿病,神經疾病,腫瘤,抗發炎性疾病,其他)
    • 藥物輸送的各途徑 (口服,局部,非口服,其他)
    • 各形狀 (錠劑,膠囊,注射,其他)
    • 各採購處 (自家公司製造/CMO (委託製造機關))
    • 各流通管道 (醫院藥局,零售藥局,線上藥局,其他)
    • 各地區
    • 各企業 (2020年)
  • 產品市場地圖

第7章 北美的學名藥市場:未來展望

  • 市場規模與其預測
  • 市場佔有率與其預測
  • 北美市場:各國分析
    • 美國的學名藥市場預測
    • 加拿大的學名藥市場預測
    • 墨西哥的學名藥市場預測

第8章 歐洲的學名藥市場:未來展望

  • 市場規模與其預測
  • 市場佔有率與其預測
  • 歐洲市場:各國分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第9章 亞太地區的學名藥市場:未來展望

  • 市場規模與其預測
  • 市場佔有率與其預測
  • 亞太地區市場:各國分析
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 日本

第10章 中東、非洲的學名藥市場:未來展望

  • 市場規模與其預測
  • 市場佔有率與其預測
  • 中東、非洲市場:各國分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國 (UAE)

第11章 南美的學名藥市場:未來展望

  • 市場規模與其預測
  • 市場佔有率與其預測
  • 南美市場:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢和動靜

第14章 競爭情形

  • 市場競爭預測
  • 企業簡介
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Sandoz International GmbH (Novartis AG)
    • Lupin Limited
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma Limited
    • Dr Reddy's Laboratories Ltd.
    • Fresenius Kabi AG
    • Aspen Pharmacare Holdings Limited
    • Sanofi SA
    • Cipla Ltd.
    • Novo Nordisk A/S
    • Abbott Laboratories Inc.

第15章 策略建議

第16章 TechSci Research相關資料,免責聲明

目錄
Product Code: 7332

Title:
Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Company, By Region, Forecast & Opportunities, 2026.

Global generic drugs market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a CAGR of 7.08% during the forecast period. The global generic drugs market is driven by rising prevalence of chronic diseases across the globe. Moreover, availability of generic drugs at a lower cost and having the same chemical composition of branded drugs is one of the key factors which is positively impacting the growth of market during the forecast period. Also, increasing count of drug patent expirations is further expected to bolster the growth of market over the next few years.

The global generic drugs market is segmented based on type, application, drug delivery, form, source, distribution channel, company, and region. In terms of application, the market can be categorized into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, others. Out of which, the cardiovascular diseases segment dominated the market by holding 35.05% market share in 2020 and the segment is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to majority of population dealing with cardiovascular diseases across the globe. On the contrary, diabetes segment is anticipated to register the highest growth in the coming years which can be attributed to ever increasing prevalence of diabetes predominantly in Asia-Pacific region. Also, growing use of metformin generic drug for the treatment of diabetes owing to its effectiveness, is further contributing to the segmental growth.

The major players operating in the global generic drugs market are Teva Pharmaceutical Industries Ltd, Mylan NV, Sandoz International GmbH (Novartis AG), Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, Dr Reddy's Laboratories Ltd., Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Sanofi S.A., Cipla Ltd., Novo Nordisk A/S, Abbott Laboratories Inc., and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer base.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze historical growth in market size of global generic drugs market from 2016 to 2019.
  • To estimate and forecast the market size of global generic drugs market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global generic drugs market based on type, application, drug delivery, form, source, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global generic drugs market.
  • To identify drivers and challenges for global generic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global generic drugs market.
  • To conduct pricing analysis for global generic drugs market.
  • To identify and analyze the profiles of leading players operating in global generic drugs market.
  • To identify key sustainable strategies adopted by market players in global generic drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global generic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Generic drugs manufacturers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to generic drugs

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Generic Drugs Market, By Type:

Small Molecule Generics

Biosimilars

  • Global Generic Drugs Market, By Application:

Cardiovascular Diseases

Diabetes

Neurology

Oncology

Anti-Inflammatory Diseases

Others

  • Global Generic Drugs Market, By Drug Delivery:

Oral

Topical

Parenteral

Others

  • Global Generic Drugs Market, By Form:

Tablet

Capsule

Injection

Others

  • Global Generic Drugs Market, By Source:

In House

Contract Manufacturing Organizations

  • Global Generic Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

  • Global Generic Drugs Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in global generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Generic Drugs Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Factors driving Global Generic Drugs Market
  • 5.3. Factors Influencing Drug Purchase Decision

6. Global Generic Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Small Molecule Generics vs Biosimilars)
    • 6.2.2. By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)
    • 6.2.3. By Drug Delivery (Oral, Topical, Parenteral, Others)
    • 6.2.4. By Form (Tablet, Capsule, Injection, Others)
    • 6.2.5. By Source (In House vs Contract Manufacturing Organizations)
    • 6.2.6. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
    • 6.2.7. By Region
    • 6.2.8. By Company (2020)
  • 6.3. Product Market Map

7. North America Generic Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Drug Delivery
    • 7.2.4. By Form
    • 7.2.5. By Source
    • 7.2.6. By Distribution Channel
    • 7.2.7. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Generic Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Drug Delivery
        • 7.3.1.2.4. By Form
        • 7.3.1.2.5. By Source
        • 7.3.1.2.6. By Distribution Channel
    • 7.3.2. Canada Generic Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Drug Delivery
        • 7.3.2.2.4. By Form
        • 7.3.2.2.5. By Source
        • 7.3.2.2.6. By Distribution Channel
    • 7.3.3. Mexico Generic Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Drug Delivery
        • 7.3.3.2.4. By Form
        • 7.3.3.2.5. By Source
        • 7.3.3.2.6. By Distribution Channel

8. Europe Generic Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Drug Delivery
    • 8.2.4. By Form
    • 8.2.5. By Source
    • 8.2.6. By Distribution Channel
    • 8.2.7. By Country (France; Germany; UK; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Generic Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Drug Delivery
        • 8.3.1.2.4. By Form
        • 8.3.1.2.5. By Source
        • 8.3.1.2.6. By Distribution Channel
    • 8.3.2. France Generic Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Drug Delivery
        • 8.3.2.2.4. By Form
        • 8.3.2.2.5. By Source
        • 8.3.2.2.6. By Distribution Channel
    • 8.3.3. United Kingdom Generic Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Drug Delivery
        • 8.3.3.2.4. By Form
        • 8.3.3.2.5. By Source
        • 8.3.3.2.6. By Distribution Channel
    • 8.3.4. Italy Generic Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Drug Delivery
        • 8.3.4.2.4. By Form
        • 8.3.4.2.5. By Source
        • 8.3.4.2.6. By Distribution Channel
    • 8.3.5. Spain Generic Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Drug Delivery
        • 8.3.5.2.4. By Form
        • 8.3.5.2.5. By Source
        • 8.3.5.2.6. By Distribution Channel

9. Asia-Pacific Generic Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Drug Delivery
    • 9.2.4. By Form
    • 9.2.5. By Source
    • 9.2.6. By Distribution Channel
    • 9.2.7. By Country (China; India; Japan; South Korea; Australia)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Generic Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Drug Delivery
        • 9.3.1.2.4. By Form
        • 9.3.1.2.5. By Source
        • 9.3.1.2.6. By Distribution Channel
    • 9.3.2. India Generic Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Drug Delivery
        • 9.3.2.2.4. By Form
        • 9.3.2.2.5. By Source
        • 9.3.2.2.6. By Distribution Channel
    • 9.3.3. Australia Generic Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Drug Delivery
        • 9.3.3.2.4. By Form
        • 9.3.3.2.5. By Source
        • 9.3.3.2.6. By Distribution Channel
    • 9.3.4. South Korea Generic Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By Drug Delivery
        • 9.3.4.2.4. By Form
        • 9.3.4.2.5. By Source
        • 9.3.4.2.6. By Distribution Channel
    • 9.3.5. Japan Generic Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By Drug Delivery
        • 9.3.5.2.4. By Form
        • 9.3.5.2.5. By Source
        • 9.3.5.2.6. By Distribution Channel

10. Middle East and Africa Generic Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Drug Delivery
    • 10.2.4. By Form
    • 10.2.5. By Source
    • 10.2.6. By Distribution Channel
    • 10.2.7. By Country (UAE; Saudi Arabia; South Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Generic Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Drug Delivery
        • 10.3.1.2.4. By Form
        • 10.3.1.2.5. By Source
        • 10.3.1.2.6. By Distribution Channel
    • 10.3.2. Saudi Arabia Generic Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Drug Delivery
        • 10.3.2.2.4. By Form
        • 10.3.2.2.5. By Source
        • 10.3.2.2.6. By Distribution Channel
    • 10.3.3. UAE Generic Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Drug Delivery
        • 10.3.3.2.4. By Form
        • 10.3.3.2.5. By Source
        • 10.3.3.2.6. By Distribution Channel

11. South America Generic Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By Drug Delivery
    • 11.2.4. By Form
    • 11.2.5. By Source
    • 11.2.6. By Distribution Channel
    • 11.2.7. By Country (Brazil; Argentina; Colombia)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Generic Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Drug Delivery
        • 11.3.1.2.4. By Form
        • 11.3.1.2.5. By Source
        • 11.3.1.2.6. By Distribution Channel
    • 11.3.2. Argentina Generic Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Drug Delivery
        • 11.3.2.2.4. By Form
        • 11.3.2.2.5. By Source
        • 11.3.2.2.6. By Distribution Channel
    • 11.3.3. Colombia Generic Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Drug Delivery
        • 11.3.3.2.4. By Form
        • 11.3.3.2.5. By Source
        • 11.3.3.2.6. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Teva Pharmaceutical Industries Ltd.
    • 14.2.2. Mylan NV
    • 14.2.3. Sandoz International GmbH (Novartis AG)
    • 14.2.4. Lupin Limited
    • 14.2.5. Pfizer Inc.
    • 14.2.6. Sun Pharmaceutical Industries Limited
    • 14.2.7. Endo Pharmaceuticals Inc.
    • 14.2.8. Aurobindo Pharma Limited
    • 14.2.9. Dr Reddy's Laboratories Ltd.
    • 14.2.10. Fresenius Kabi AG
    • 14.2.11. Aspen Pharmacare Holdings Limited
    • 14.2.12. Sanofi SA
    • 14.2.13. Cipla Ltd.
    • 14.2.14. Novo Nordisk A/S
    • 14.2.15. Abbott Laboratories Inc.

15. Strategic Recommendations

16. About Us and Disclaimer

List of Figures

  • Figure 1: Global Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 3: Global Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 4: Global Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 5: Global Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 6: Global Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 7: Global Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 8: Global Generic Drugs Market Share, By Company, 2016-2026F
  • Figure 9: Global Generic Drugs Market Share, By Region, 2016-2026F
  • Figure 10: Global Generic Drugs Product Market Map, By Region, By Value, 2016-2026F
  • Figure 11: North America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 12: North America Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 13: North America Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 14: North America Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 15: North America Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 16: North America Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 17: North America Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 18: North America Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 19: United States Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 20: United States Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 21: United States Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 22: United States Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 23: United States Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 24: United States Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 25: United States Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 26: Canada Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 27: Canada Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 28: Canada Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 29: Canada Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 30: Canada Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 31: Canada Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 32: Canada Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 33: Mexico Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 34: Mexico Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 35: Mexico Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 36: Mexico Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 37: Mexico Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 38: Mexico Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 39: Mexico Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 40: Europe Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 41: Europe Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 42: Europe Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 43: Europe Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 44: Europe Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 45: Europe Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 46: Europe Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 47: Europe Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 48: Germany Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: Germany Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 50: Germany Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 51: Germany Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 52: Germany Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 53: Germany Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 54: Germany Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 55: France Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 56: France Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 57: France Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 58: France Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 59: France Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 60: France Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 61: France Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 62: United Kingdom Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 63: United Kingdom Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 64: United Kingdom Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 65: United Kingdom Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 66: United Kingdom Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 67: United Kingdom Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 68: United Kingdom Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 69: Italy Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 70: Italy Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 71: Italy Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 72: Italy Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 73: Italy Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 74: Italy Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 75: Italy Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 76: Spain Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 77: Spain Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 78: Spain Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 79: Spain Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 80: Spain Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 81: Spain Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 82: Spain Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 83: Asia Pacific Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 84: Asia Pacific Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 85: Asia Pacific Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 86: Asia Pacific Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 87: Asia Pacific Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 88: Asia Pacific Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 89: Asia Pacific Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 90: Asia Pacific Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 91: China Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 92: China Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 93: China Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 94: China Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 95: China Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 96: China Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 97: China Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 98: India Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 99: India Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 100: India Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 101: India Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 102: India Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 103: India Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 104: India Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 105: Australia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 106: Australia Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 107: Australia Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 108: Australia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 109: Australia Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 110: Australia Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 111: Australia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 112: South Korea Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 113: South Korea Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 114: South Korea Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 115: South Korea Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 116: South Korea Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 117: South Korea Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 118: South Korea Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 119: Japan Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 120: Japan Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 121: Japan Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 122: Japan Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 123: Japan Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 124: Japan Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 125: Japan Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 126: South America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 127: South America Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 128: South America Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 129: South America Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 130: South America Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 131: South America Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 132: South America Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 133: South America Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 134: Brazil Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 135: Brazil Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 136: Brazil Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 137: Brazil Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 138: Brazil Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 139: Brazil Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 140: Brazil Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 141: Argentina Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 142: Argentina Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 143: Argentina Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 144: Argentina Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 145: Argentina Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 146: Argentina Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 147: Argentina Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 148: Colombia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 149: Colombia Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 150: Colombia Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 151: Colombia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 152: Colombia Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 153: Colombia Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 154: Colombia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 155: Middle East & Africa Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 156: Middle East & Africa Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 157: Middle East & Africa Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 158: Middle East & Africa Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 159: Middle East & Africa Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 160: Middle East & Africa Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 161: Middle East & Africa Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 162: Middle East & Africa Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 163: South Africa Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 164: South Africa Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 165: South Africa Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 166: South Africa Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 167: South Africa Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 168: South Africa Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 169: South Africa Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 170: Saudi Arabia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 171: Saudi Arabia Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 172: Saudi Arabia Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 173: Saudi Arabia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 174: Saudi Arabia Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 175: Saudi Arabia Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 176: Saudi Arabia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 180: UAE Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 181: UAE Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 182: UAE Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 183: UAE Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 184: UAE Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 185: UAE Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 186: UAE Generic Drugs Market Share, By Distribution Channel, 2016-2026F